Inhibition of SARS-CoV-2 main protease 3CLpro by means of α-ketoamide and pyridone-containing pharmaceuticals using in silico molecular docking
Amin O. Elzupir
Topics & Concepts
ChemistryIndinavirPharmacologyDocking (animal)AutoDockIn silicoAmprenavirOseltamivirVirologyCoronavirusProteaseBiochemistryVirusEnzymeCoronavirus disease 2019 (COVID-19)MedicineViral loadVeterinary medicineGeneHIV-1 proteaseInfectious disease (medical specialty)DiseasePathologyAntiretroviral therapyComputational Drug Discovery MethodsSARS-CoV-2 and COVID-19 ResearchSynthesis and biological activity